首页> 外文期刊>Journal of Drug Delivery and Therapeutics >FORMULATION AND EVALUATION OF ONCE DAILY SUSTAINED RELEASE MATRIX TABLET OF VERAPAMIL HYDROCHLORIDE
【24h】

FORMULATION AND EVALUATION OF ONCE DAILY SUSTAINED RELEASE MATRIX TABLET OF VERAPAMIL HYDROCHLORIDE

机译:盐酸维拉帕米一次持续释放矩阵片的研制与评价

获取原文
           

摘要

Matrix tablets of Verapamil Hydrochloride were formulated as sustained release tablet employing sodium alginate, hydroxyl propyl methyl cellulose polymer, Ethyl cellulose and the sustainedrelease tablets was investigated. Sustained release matrix tablets contain 240 mg Verapamil Hydrochloride were developed using different drug polymer concentration of HPMC, Sodium Alginate and Ethyl Cellulose. Tablets were prepared by wet granulation using HPMCand water solution. Formulation was optimized on the basis of acceptable tablet properties and in-vitro drug release. The resulting formulation produced robust tablets with optimum hardness, thickness consistent weight uniformity and low friability. All tablets but one exhibited gradual and near completion sustained release for Verapamil Hydrochloride, and 99% to 101% released at the end of 24 hrs. The results of dissolution studies indicated that formulation F8, the most successful of the study. An increase in release kinetics of the drug was observed on decreasing polymer concentration.
机译:用海藻酸钠,羟丙基甲基纤维素聚合物,乙基纤维素将维拉帕米盐酸盐的基质片剂制成缓释片剂,并研究了缓释片剂。使用不同浓度的HPMC,藻酸钠和乙基纤维素开发了含有240毫克维拉帕米盐酸盐的缓释基质片剂。使用HPMC和水溶液通过湿法制粒制备片剂。基于可接受的片剂性质和体外药物释放来优化制剂。所得制剂产生具有最佳硬度,厚度一致的重量均匀性和低脆性的坚固片剂。除一种片剂外,所有片剂均显示出逐步和接近完成的盐酸维拉帕米缓释作用,在24小时结束时释放出99%至101%。溶出度研究的结果表明制剂F8是研究中最成功的。在降低聚合物浓度时观察到药物的释放动力学增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号